Spin-lattice relaxation time in drug discovery and design

Current Topics in Medicinal Chemistry

Volumn 9, Issue 9, 2009, Pages 811-823

  Figueroa Villar, José Daniel ^a   Tinoco, Luzineide Wanderley ^b  

^a MILITARY INSTITUTE OF ENGINEERING   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

CSP; HTS; Intermolecular interaction; NMR; Nuclear relaxation; Spin lattice relaxation time; Topology of interaction

Indexed keywords

BENDAZAC LYSINE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID; TOLMETIN; LIGAND; PROTEIN;

DRUG DESIGN; DRUG STRUCTURE; FLUORINE NUCLEAR MAGNETIC RESONANCE; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; CHEMISTRY; DRUG DEVELOPMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING;

DRUG DESIGN; DRUG DISCOVERY; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEINS;

EID: 73449136407     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802609789207082     Document Type: Review

References (98)

1. Stockman B. J. NMR spectroscopy as a tool for structure-based drug design. Prog. Nucl. Magn. Reson. Spectrosc., 1998, 33, 109-151.
2. Shapiro, M. Applications of NMR screening in the pharmaceutical industry. Il Farmaco 2001, 56, 141-143.
3. Diercks, T.; Coles, M.; Kessler, H. Applications of NMR in drug discovery. Curr. Opin. Chem. Biol., 2001, 5, 285-291.
4. Stockman, B. J.; Dalvit, C. NMR screening techniques in drug discovery and drug design. Prog. Nucl. Magn. Reson. Spectrosc. 2002, 41, 187-231.
5. Dalvit, C.; Flocco, M.; Knapp, S.; Mostardini, M.; Perego, R.; Stockman, B. J.; Veronesi, M.; Varasi, M. High-throughput NMR-based screening with competition binding experiments. J. Am. Chem. Soc., 2002, 124, 7702-7709.
6. Pellecchia, M.; Sem, D. S.; Wuthrich, K. NMR in drug discovery. Nat. Rev. Drug Discov., 2002, 1, 211-219.
7. Coles, M.; Heller, M.; Kessler, H. NMR-based screening technologies. Drug Discov. Today 2003, 8, 803-810.
8. Fernandez, C.; Jahnke, W. New approaches for NMR screening in drug discovery. Drug Discov. Today. Technol., 2004, 1, 277-283.
9. Peng, J. W.; Moore, J.; Abdul-Manan, N. NMR experiments for lead generation in drug discovery. Prog. Nucl. Magn. Reson. Spectrosc., 2004, 44, 225-256.
10. Pellecchia, M. Solution nuclear magnetic resonance spectroscopy techniques for probing intermolecular interactions. Chem. Biol., 2005, 12, 961-971.
11. Fielding, L. NMR methods for the determination of protein-ligand dissociation constants. Prog. Nucl. Magn. Reson. Spectrosc., 2007, 51, 219-242.
12. Shortridge, M. D.; Hage, D. S.; Harbison, G. S.; Powers, R. Estimating protein-ligand binding affinity using high-throughput screening by NMR. J. Comb. Chem., 2008, 10, 948-958.
13. Pellecchia, M.; Bertini, I.; Cowburn, D.; Dalvit, C.; Giralt, E.; Jahnke, W.; James, T. L.; Homans, S. W.; Kessler, H.; Luchinat, C.; Meyer, B.; Oschinat, H.; Peng, J.; Schwalbe, H.; Siegal, G. Perpectives on NMR in drug discovery: a technique comes of age. Nat. Rev. Drug Discov., 2008, 7, 738-745.
14. Frickel, E. M.; Riek, R.; Jelesarov, I.; Helenius, A.; Wuthrich, K.; Ellgaard, L. TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc. Natl. Acad. Sci. USA, 2002, 99, 1954-1959.
15. Fernandez, C.; Wider, G. TROSY in NMR studies of the structure and function of large biological macromolecules. Curr. Opin. Struct. Biol., 2003, 13, 570-580.
16. Bai, G.; Cui, Y.; Yang, Y.; Ye, C.; Liu, M. A competitive low-affinity binding model for determining the mutual and specific sites of two ligands on protein. J. Pharm. Biomed. Anal., 2005, 38, 588-593.
17. Powers, R.; Mercier, K. A.; Copeland, J. C. The application of FAST-NMR for the identification of novel drug discovery targets. Drug Discov. Today, 2008, 13, 172-180.
18. Mercier, K. A.; Baran, M.; Ramanathan, V.; Revesz, P.; Xiao, R.; Montelione, G. T.; Powers, R. FAST-NMR: Functional annotation screening technology using NMR spectroscopy. J. Am. Chem. Soc., 2006, 128, 15292-152-99.
19. Todd, A. E.; Mardsen, R. L.; Thornton, J. M.; Orengo, C. A. Progress of structural genomics initiatives: an analysis of solved target structures. J. Mol. Biol., 2005, 348, 1235-1260.
20. Lee, Y.-H.; Moon, I. J.; Park, J. H.; Han, K. H.; Uhm, S. Y.; Kim, Y. J.; Kang, K. J.; Park, J. W.; Seu, Y. B.; Kim, Y. H.; Park, J. G. Gene knockdown by large circular antisense for high throughput functional genomics. Nat. Biotechnol., 2005, 23, 591-599.
21. Livingstone, C. D.; Barton, G. J. Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. CABIOS. Comput. Appl. Biosci., 1993, 9, 745-756.
22. Campbell, S.J.; Gold, N. D.; Jackson, R. M.; Westhead, D. R. Ligand binding: functional site location, similarity and docking. Curr. Opin. Struct. Biol., 2003, 13, 389-395.
23. Greaves, R.; Warwicker, J. Active site identification through geometry based and sequence profile-based calculations: burial of catalytic clefts. J. Mol. Biol., 2005, 349, 547-557.
24. Bateman, A.; Birney, E. Searching databases to find protein domain organization. Adv. Protein Chem., 2000, 54, 137-157.
25. Bodenhausen, G.; Ruben, D. J. Natural abundance N-15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett., 1980, 69, 185-189.
26. Sousa, S. F.; Fernandes, P. A.; Ramos, M. J. Protein-ligand docking: Current status and future challenges. Proteins, 2006, 65, 15-26.
27. Powers, R.; Copeland, J. C.; Germer, K.; Mercier, K. A.; Ramanathan, V.; Revesz, P. Comparison of protein active site structures for functional annotation of proteins and drug design. Proteins, 2006, 65, 124-135.
28. Dietmann, S.; Park, J.; Notredame, C.; Heger, A.; Lappe, M.; Holm, L. A fully automatic evolutionary classification of protein, folds: Dali Domain Dictionary version 3. Nucleic Acids Res., 2001, 29, 55-57.
29. Goodsell, D. S.; Morris, G. M.; Olson, A. J. Automated docking of flexible ligands: Applications of AutoDock. J. Mol. Recognit., 1996, 9, 1-5.
30. Silva, O. F; Fernández, M. A.; Pennie, S. L.; Gil, R. R.; de Rossi, R. H. Synthesis and characterization of an amphiphilic cyclodextrin, a micelle with two recognition sites. Langmuir 2008, 24, 3718-3726.
31. Veglia, G.; Delfini, M.; del Giudice, M. R.; Gaggelli, E.; Valensin, G. H-1 NMR studies on the interaction of beta-carboline derivatives with human serum albumin. J. Magn. Reson., 1998, 130, 281-286.
32. Cui, Y. F.; Bai, G. Y.; Li, C. G.; Ye, C. H; Liu, M. L. Analysis of competitive ligands to human serum albumin using NMR relaxation measurements. J. Pharmacol. Biomed. Anal., 2004, 34, 247-254.
33. Freeman, R.; Hill, H. D. W., Fourier transform study of the spin-lattice relaxation by "progressive-saturation". J. Chem. Phys. 1971, 54, 3367-3377.
34. Markley, J. L.; Horsey, W. J.; Klein M. P., Spin-lattice relaxation measurements in slowly relaxing complex spectra. J. Chem. Phys., 1971, 55, 3604-3605.
35. Vold, R. L.; Waugh, J. S.; Klein, M. P.; Phelps D. E., Measurement of spin relaxation in complex systems. J. Chem. Phys., 1968, 48, 3831-3832.
36. Freeman, R.; Hill, H. D. W.; Tomlinson, B. L.; Hall, L. D. Dipolar contribution to NMR spin-lattice relaxation of protons. J. Chem. Phys., 1974, 61, 4466-4473.
37. Niccolai, N.; de Miles, M. P. L.; Hehir, S. P.; Gibbons, W. A. Correlation time measurements of amino acid side chains from proton selective spin-lattice relaxation rates. J. Am. Chem. Soc., 1978, 100, 6528-6529.
38. Valensin, G.; Kushnir, T.; Navon, G. Selective and non-selective proton spin-lattice relaxation studies of enzyme-substrate interactions. J. Magn. Reson., 1982, 46, 23-29.
39. Tinoco, L. W.; Figueroa-Villar, J. D. Determination of correlation times from selective and non-selective spin lattice relaxation rates and their use in drug-drug and drug-albumin interaction studies. J. Braz. Chem. Soc., 1999, 10, 281-286.
40. Bonechi, C.; Donati, A.; Picchi, M. P.; Rossi, C.; Tiezzi, E. DNA-ligand interactions detected by proton selective and non-selective spin-lattice relaxation rate analysis. Coll. Surf. A., 1996, 115, 89-95.
41. Venâncio, T; Engelsberg, M.; Avevedo, R. B. V.; Alem, N. E. R.; Colnago, L. A. Fast simultaneous measurement of longitudinal and transverse NMR relaxation times in a single continuous wave free precession experiment. J. Magn. Reson., 2005, 173, 34-39.
42. Delfini, M.; Bianchetti, C.; Di Cocco, M.E.; Pescosolido, N.; Porcelli, F.; Rosa, R.; Rugoa, G. An NMR spectroscopy study of bendaline-albumin interactions. Bioorg. Chem., 2003, 31, 378-388.
43. 2 and its complex with propamidine from NMR and molecular modeling. Biochim. Biophys. Acta 1997, 1350, 205-220.
44. Schwendhelm, K. F.; Horstmann, M.; Faber, J. H.; Reichert, Y.; Bringmann, G.; Faber, C. The novel antimalarial compound dioncophylline C forms a complex with heme in solution. Chem. Med. Chem., 2007, 2, 543-548.
45. Casu , M.; Puligheddu , S.; Saba , G.; Marincola, F. C.; Orellana , G.; Lai, A. The interaction of DNA with intercalating agents probed by sodium-23 NMR relaxation rates. J. Biomol. Struct. Dyn., 1997, 15, 37-43.
46. Casu, M.; Saba, G.; Lai, A.; Luhmer, M.; KirschDeMesmaeker, A.; Moucheron, C.; Reisse, J. Binding of Ru(II) polyazaaromatic complexes to DNA: A Na-23 NMR spin-lattice relaxation study. Biophys. Chem., 1996, 59, 133-138.
47. Rossi C.; Donati, A.; Sansoni, M. R. Nuclear-magnetic-resonance as a tool for the identification of specific DNA-ligand interaction. Chem. Phys. Lett., 1992, 189, 278-280.
48. Cellmer, T.; Henry, E. R.; Hofrichter, J.; Eaton, W. A. Measuring internal friction of an ultrafast-folding protein. Proc. Natl. Acad. Sci. USA, 2008, 105, 18320-18325.
49. Sega, E. M.; Tormena, C. F.; de Oliveira, P. R;, R. Rittner; Tinoco, L. W.; Figueroa-Villar, J. D.; Hoehr, N. F. Solvent effects in the (2)J(HH), (3)J(HH), (1)J(NC) and (2)J(NC) coupling constants in the NMR spectrum of acetylcholine chloride. J. Mol. Struct., 2006, 797, 44-48.
50. Dzik-Jurasz; A. S. K.; Leach, M. O.; Rowland, I. J. Investigation of microenvironmental factors influencing the longitudinal relaxation times of drugs and other compounds. Magn. Reson. Imag., 2004, 22, 973-982.
51. Sulkoska, A.; Maciazek-Jurczyk, M.; Bojko, B.; Równica, J.; Sulkowski, W. W. 1H NMR study of methotrexate-serum albumin (MTX-SA) binding in reumathoid arthritis. J. Mol. Struct., 2008, 891, 278-283.
52. Luo, R. S.; Liu, M. L.; Mao, X. A. NMR diffusion and relaxation study of drug-protein interaction. Spectrochim. Acta A, 1999, 55, 1897-1901.
53. 1H NMR studies of the interaction of tricyclic antidepressant drugs with dodecyl-dimethylammonium chloride micelles. J. Phys. Chem., 1992, 96, 3146-3151.
54. Calzolai, L.; Gaggelli, E.; Maccotta, A.; Valensin G., Interaction of daunomycin with dipalmitoylphosphatidylcholine model membranes. A 1H NMR study. J. Magn. Reson. B, 1996, 112, 228-235.
55. Borges, N. N.; Figueroa-Villar J. D., Interaction of aromatic guanyl hydrazones with micelles by NMR: A model for the mechanism of action of cationic antibiotics. Biopolymers, 2001, 62, 9-14.
56. Borges, N. N.; Messeder, J. C.; Figueroa-Villar, J. D. Synthesis, trypanocidal activity and micelle interaction studies of biguanylhydrazones analogous to pentamidine. Eur. J. Med. Chem., 2004, 39, 925-929.
57. de Carvalho, E. M.; Velloso, M. H. R.; Tinoco, L. W.; Figueroa-Villar, J. D. Formation of p-cresol:piperazine complex in solution monitored by spin-lattice relaxation times and pulsed field gradient NMR diffusion measurements. J. Magn. Reson., 2003, 164, 197-204.
58. Liu, M.; Farant, R. D.; Lindon, J. C. Measurement of interproton distances from cross-relaxation rates determined by a selective NULL inversion-recovery NMR method. Magn. Reson. Chem., 1992, 30, 173-176.
59. Blobel, J.; Fayos, R.; Garcia, J.; Marimon, O.; Pérez, Y.; Pons, M. Low-molecular-weight spies of protein-protein interactions. Compt. Rend. Chim., 2008, 11, 499-505.
60. 1H NMR relaxometric study. Biophys. Chem., 2007, 129, 29-35.
61. Behling, R. W.; Yamane, T.; Navon, G.; Sammon, M. J.; Jelinski, L. W. Measuring relative acetylcholine receptor agonist binding by selective proton nuclear magnetic resonance relaxation experiments. Biophys. J., 1988, 53, 947-954.
62. Luz, C.; Meiboom, G. Proton relaxation in dilute solutions of cobalt (II) and nickel (II) ions in methanol and the rate of methanol exchange of the solvent sphere. J. Chem. Phys., 1964, 40, 2686-2692.
63. 1 NMR relaxation. Biochemistry, 1990, 29, 2617-2622.
64. Berkowitz, D. B.; Karukurichi, K. R.; Salud-Bea, R.; Nelson, D. L.; McCune, C. D. Use of fluorinated functionality in enzyme inhibitor development: Mechanistic and analytical advantages. J. Fluor. Chem., 2008, 129, 731-742.
65. Dalvit. C.; Fagerness, P. E.; Hadden, D. T. A.; Sarver, R. W.; Stockman, B. J. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. J. Am. Chem. Soc., 2003, 125, 7696-7703.
66. Dalvit. C. Ligand- and substrate-based 19F NMR screening: Principles and applications to drug discovery. Progr. Nucl. Magn. Reson. Spectrosc., 2007, 51, 243-271.
67. Papeo,G.; Giordano, P.; Brasca, M. G.; Buzzo, F.; Caronni, D.; Ciprandi, F.; Mongelli, N.; Veronesi, M. ; Vulpetti, A.; Dalvit, C. Polyfluorinated amino acids for sensitive 19F NMR-based screening and kinetic measurements. J. Am. Chem. Soc., 2007, 129, 5665-5672.
68. 19F NMR-based screening experiments: Theoretical considerations and experimental applications. J. Am. Chem. Soc., 2005, 127, 13380-13385.
69. 19F nuclear magnetic resonance spin-lattice relaxation time measurement. Talanta, 1999, 49, 261-265.
70. Becker, B. A.; Larive, C. K. Probing the binding of propanolol enantiomers to α-acid glycoprotein with ligand-detected NMR experiments. J. Phys. Chem. B, 2008, 112, 13581-13587.
71. Blommers, M. J. J.; Strauss, A.; Geiser, M.; Ramage, P.; Sparrer, H.; Jahnke, W. NMR-based strategies to elucidate bioactive conformations of weakly binding ligands. Top. Curr. Chem., 2008, 273, 1-14.
72. Babailov, S. P. Lanthanide paramagnetic probes for NMR spectroscopic studies of molecular conformational dynamics in solution: Applications to macrocyclic molecules. Prog. Nucl. Magn. Reson. Spectrosc., 2008, 52, 1-21.
73. Gillespie, J. R.; Shortle, D. Characterization of long range structure in the denatured state of staphylococcal nuclease. I. Paramagnetic relaxation enhancement by nitroxide spin labels. J. Mol. Biol., 1997, 268, 158-169.
74. Gillespie, J. R.; Shortle, D. Characterization of long range structure in the denatured state of staphylococcal nuclease II. Distance restraints from paramagnetic relaxation and calculation of an ensemble of structures. J. Mol. Biol. 1997, 268, 170-184.
75. Schmidt, P. G., and Kuntz, I. D. Distance measurements in spin-labeled lysozyme. Biochemistry, 1984, 23, 4261-4266.
76. Niccolai, N.; Spiga, Bernini, O. A.; Scarselli, M.; Ciutti, A.; Fiaschi, I.; Chiellini, S.; Molinari, H.; Temussi, P. A. NMR studies of protein hydration and TEMPOL accessibility. J. Mol. Biol., 2003, 332, 437-447.
77. Peterson, D. W.; Zhou, H.; Dahlquist, F. W.; Lew, J. A soluble oligomer of tau associated with fiber formation analyzed by NMR. Biochemistry, 2008, 47, 7393-7404.
78. Keizers, P. H. J.; Saragliadis, A.; H, Yoshitaka; Overhand, M.; Ubbink, M. Design, synthesis, and evaluation of a lanthanide chelating protein probe: CLaNP-5 yields predictable paramagnetic effects independent of environment. J. Am. Chem. Soc., 2008, 130, 14802-14812.
79. Vlasie, M. D.; Fernández-Busnadiego, R.; Prudêncio, M.; Ubbink, M. Conformation of pseudoazurin in the 152 kDa electron transfer complex with nitrite reductase determined by paramagnetic NMR. J. Mol. Biol., 2008, 375, 1405-1415.
80. Prudêncio, M., Rohovec, J., Peters, J. A., Tocheva, E., Boulanger,M. J., Murphy, M. E. Hupkes, H. J.; Kosters, W.; Impagliazzo, A.; Ubbink, M. A caged lanthanide complex as a paramagnetic shift agent for protein NMR. Chem. Eur. J., 2004, 10, 3252-3260.
81. Dunaway-Mariano, D.; Cleland, W. W. Preparation and properties of chromium III adenosine 5′-triphosphate chromium III, adenosine 5′-diphosphate and related chromium III complex. Biochemistry, 1980, 19, 1496-1505.
82. Abbassi, F.; Galanth, C.; Amiche, M.; Saito, K.; Piesse, C.; Zargarian, L.; Hani, K.; Nicolas, P.; Lequin, O.; Ladram, A. Solution structure and model membrane interactions of temporins-SH, antimicrobial peptides from amphibian skin. A NMR spectroscopy and differential scanning calorimetry study. Biochemistry, 2008, 47, 10513-10525.
83. Battiste, J. L.; Wagner, G. Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear Overhauser effect data. Biochemistry, 2000, 39, 5355-5365.
84. Lindfors, H. E.; de Koning, P. E.; Drijfhout, J. W.; Venezia, B.; Ubbink, M. Mobility of TOAC spin-labelled peptides binding to the Src SH3 domain studied by paramagnetic NMR. J. Biomol. NMR, 2008, 41, 157-167.
85. Kale, S.; Ulas, G.; Song, J.; Brudvig, G. W.; Furey, W.; Jordan, F. Efficient coupling of catalysis and dynamics in the E1 component of Escherichia coli pyruvate dehydrogenase multienzyme complex. Proc. Natl. Acad. Sci. USA, 2008, 105, 1158-1163.
86. Jensen, M. R.; Hansen, D. F.; Ayna, U.; Dagil, R.; Hass, M. A. S.; Christensen, H. E. M.; Led, J. J. On the use of pseudocontact shifts in the structure determination of metalloproteins. Magn. Reson. Chem., 2006, 44, 294-301.
87. Banci, L.; Piccioli, M.; Arnesano, F. NMR structures of paramagnetic metalloproteins. Q Rev. Biophys., 2005, 38, 167-219.
88. Dancheck, B.; Nairn, A. C. and Peti, W. Detailed structural characterization of unbound protein phosphatase 1 inhibitors. Biochemistry, 2008, 47, 12346-12356.
89. Amero, C. D.; Boomershine, W. P.; Xu, Y.; Foster, M. Solution structure of Pyrococcus furiosus RPP21, a component of the archaeal RNase P holoenzyme, and interactions with Its RPP29 protein partner. Biochemistry, 2008, 47, 11704-11710.
90. Tomaselli, S.; Zanzoni, S.; Ragona, L.; Gianolio, E.; Aime, S.; Assfalg, M.; Molinari, H. Solution structure of the supramolecular adduct between a liver cytosolic bile acid binding protein and a bile acid-based gadolinium(III)- chelate, a potential hepatospecific magnetic resonance imaging contrast agent. J. Med. Chem., 2008, 51, 6782-6792.
91. Jakeman, D. L.; Ivory, A. J., Blackburn, G. M.; Williamson, M. P. Orientation of 1,3-bisphosphoglycerate analogs bound to phosphoglycerate kinase. J. Biol. Chem., 2003, 278, 10957-10962.
92. Lee, G. M.; Pufall, M. A.; Meeker, C. A.; Kang, H.S.; Graves, B. J.; McIntosh, L. P. The affinity of ETS-1 for DNA is modulated by phosphorylation through transient interactions of an unstructured region. J. Mol. Biol., 2008, 382, 1014-1030.
93. Cruzeiro-Silva, C.; Gomes-Neto, F.; Tinoco, L. W.; Cilli, E. M.; Barros, P.V.R.; Lapido-Loureiro, P.A.; Bisch, P. M.; Almeida, F. C. L.; Valente, A. P. Structural biology of membrane-acting peptides: Conformational plasticity of anticoccidial peptide PW2 probed by solution NMR. Biochim. Biophys. Acta 2007, 1768, 3182-3192.
94. Pizzanelli, S.; Forte, C.; Monti, S. Study of the interaction of gfg tripeptide with cesium perfluorooctanoate micelles by means of NMR Spectroscopy and MD simulations. Langmuir, 2008, 24, 5809-5815.
95. Pintacuda, G.; Otting, G. Identification of protein surfaces by NMR measurements with a paramagnetic Gd(III) chelate. J. Am. Chem. Soc., 2002, 124, 372-373.
96. Niccolai, N.; Spadaccini, R.; Scarselli, M.; Bernini, A.; Crescenzi, O.; Spiga, O.; Ciutti, A.; Di Maro, D.; Bracci, L.; Dalvit, C.; Temussi, P. A. Probing the surface of a sweet protein: NMR study of MNEI with a paramagnetic probe. Protein Sci., 2001, 10, 1498-1507.
97. Niccolai, N.; Ciutti, A.; Spiga, O.; Scarselli, M.; Bernini, A.; Bracci, L.; Di Maro, D.; Dalvit, C.; Molinari, H.; Esposito, G.; Temussi, P. A. NMR studies of protein surface accessibility. J. Biol. Chem., 2001, 276, 42455-42461.
98. Poppe, L.; Harvey, T. S.; Mohr, C.; Zondlo, J.; Tegley, C. M.; Nuanmanee, O.; Cheetham, J. Discovery of ligands for NURR1 by combined use of NMR screening with different isotopic and spin-labeling strategies. J. Biomol. Screen., 2007, 301-311.